Patients with these tumors are typically symptomatic, often secrete ectopic hormones (e.g., ACTH in 40% of tumors) and, like neuroendocrine tumors of the lung, secrete circulating biomarkers such as chromogranin A and 5-HIAA (metabolite of serotonin). This evidence concerns the gene CHGA and neuroendocrine neoplasm.